Chronic hepatitis B
Showing 1 - 25 of >10,000
Chronic Hepatitis B Trial (Imdusiran (AB-729))
Not yet recruiting
- Chronic Hepatitis B
- Imdusiran (AB-729)
- (no location specified)
Nov 30, 2023
Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and
Not yet recruiting
- Chronic Hepatitis B
- VIR-2218 and peginterferon alfa-2a
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene
Recruiting
- Hepatitis B, Chronic
- genotyping
-
Sohag, EgyptSohag university Hospital
Sep 4, 2023
Tenofovir Disoproxil Fumarate and Entcavir in Treatment of
Recruiting
- Chronic Hepatitis b Patients
- Tenofovir Disoproxil Fumarate and Entcavir
-
Sohag, EgyptSohag University hospitals
May 22, 2023
Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients
Not yet recruiting
- Chronic Hepatitis B Patients
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Aug 15, 2023
Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)
Enrolling by invitation
- Chronic Hepatitis B
- Non-alcoholic Fatty Liver Disease
- exercise
-
Taipei, Zhongzheng Dist., TaiwanNational Taiwan University Hospital
Jul 13, 2023
Hepatic Fibrosis on Hepatic Steatosis Using Ultrasound
Not yet recruiting
- Hepatic Steatosis
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
May 21, 2023
Chronic Hepatitis B Trial in Beijing (TCR-T)
Active, not recruiting
- Chronic Hepatitis B
- TCR-T
-
Beijing, ChinaThe Fifth Medical Center of PLA General Hospital
Jun 13, 2023
Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)
Not yet recruiting
- Chronic Hepatitis B
- HRS9950 tablets
- HRS9950 placebo tablets
- (no location specified)
Jun 7, 2023
After Long-Term Antiviral Treatment for Chronic Hepatitis B
Completed
- Chronic Hepatitis B e Antigen Positive
- Chronic Hepatitis B e Antigen Negative
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
Not yet recruiting
- Hepatitis B, Chronic
- Exposure factors
- (no location specified)
Sep 10, 2023
Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)
Recruiting
- Hepatitis B, Chronic
- AHB-137 injection
- Placebo
-
Jilin, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)
Active, not recruiting
- Chronic Hepatitis B
- NrtIs
- +2 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 20, 2023
Hepatitis B Trial in Seoul (DA-2803, DA-2803-R, Placebo of DA-2803)
Recruiting
- Hepatitis B
- DA-2803
- +3 more
-
Seoul, Korea, Republic ofThe Catholic University of Korea, Seoul
Jul 14, 2023
COVID-19 Infection and Its Clinical Prognosis in Chronic
Recruiting
- Chronic Hepatitis B
- COVID-19 Infection
- Interferon
- nucleoside analogues
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023
Metabolic Syndrome on Antiviral Response in People With Chronic
Not yet recruiting
- Chronic Hepatitis b
- (no location specified)
Jan 21, 2023
Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)
Recruiting
- Chronic HBV Infection
- Peginterferon alfa-2b combined and ETV
-
Shenzhen, ChinaShenzhen Third People Hospital
Mar 19, 2023
Chronic Hepatitis b Trial (RBD1016, RBD1016+PegIFN-a)
Not yet recruiting
- Chronic Hepatitis b
- (no location specified)
Jul 25, 2023
Chronic Hepatitis B Trial in Grafton (AHB-137 injection, Placebo)
Not yet recruiting
- Chronic Hepatitis B
- AHB-137 injection
- Placebo
-
Grafton, Auckland, New ZealandNew Zealand Clinical Research
Jan 29, 2023
Hepatic Steatosis and Chronic Hepatitis B Virus
Not yet recruiting
- Chronic Hepatitis
- Liver biopsy
-
Sohag, EgyptFaculty of medicine
Dec 28, 2022
Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)
Not yet recruiting
- Chronic Hepatitis b
- +2 more
- Anti-PD-1 antibody
- +2 more
-
Chongqing, Chongqing, ChinaThe 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023
Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis
Recruiting
- Chronic Hepatitis b
- Non-Alcoholic Fatty Liver Disease
-
Beijing, Select A State Or Province, ChinaYameng Sun
Mar 27, 2023